Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE

(ABBV)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

AbbVie : Form 8.3 -

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/19/2019 | 09:34am EST
TIDM0QCV TIDM0Y7T 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               AbbVie Inc. 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.01 common stock 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                15(th) November 2019 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                67,312,929  4.55177% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  67,312,929  4.55177% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                             3,600                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                               439                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                             2,200                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                             4,000                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                             7,100                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                                86                    88.91 
--------------  -----------------------------  ----------------------- 
   Purchase                               500                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                               900                    89.00 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,546                    88.65 
--------------  -----------------------------  ----------------------- 
   Purchase                               900                    88.67 
--------------  -----------------------------  ----------------------- 
   Purchase                             5,940                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                            15,264                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                               206                    88.63 
--------------  -----------------------------  ----------------------- 
   Purchase                               534                    87.84 
--------------  -----------------------------  ----------------------- 
     Sale                               6,291                    88.63 
--------------  -----------------------------  ----------------------- 
     Sale                                 631                    87.81 
--------------  -----------------------------  ----------------------- 
     Sale                                 780                    87.81 
--------------  -----------------------------  ----------------------- 
     Sale                                 500                    88.63 
--------------  -----------------------------  ----------------------- 
     Sale                               3,600                    88.63 
--------------  -----------------------------  ----------------------- 
     Sale                              42,576                    88.63 
--------------  -----------------------------  ----------------------- 
     Sale                              45,540                    88.63 
--------------  -----------------------------  ----------------------- 
     Sale                               1,584                    88.63 
--------------  -----------------------------  ----------------------- 
     Sale                               9,000                    88.63 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                       NO 
-------------------------------------------------------  -------------------- 
Date of disclosure                                       18(th) November 2019 
-------------------------------------------------------  -------------------- 
Contact name                                                Lionel Colaco 
-------------------------------------------------------  -------------------- 
Telephone number                                                 020 33956098 
-------------------------------------------------------  -------------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  -------------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  -------------------- 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 

(MORE TO FOLLOW) Dow Jones Newswires

11-19-19 0933ET

This article is part of a news chaine.
Article 1 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABBVIE
12/09ABBVIE : Form 8.3 -
DJ
12/09ABBVIE : More than Seven-Year Analysis of Early Treatment with IMBRUVICA Monothe..
AQ
12/09ABBVIE : New Long-Term Data Continues to Demonstrate Progression-Free Survival a..
AQ
12/09ABBVIE : IMBRUVICA plus VENCLEXTA/VENCLYXTO Combination Data Show High Rates of ..
AQ
12/09ALECTOR : Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheim..
AQ
12/09ABBVIE : and Scripps Research announce collaboration to develop a broad range of..
PR
12/06ABBVIE : Form 8.3 -
DJ
12/06ABBVIE : reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCP..
AQ
12/05ABBVIE : Form 8.3 -
DJ
12/04ABBVIE : Form 8.3 - Abbvie Inc
DJ
More news